AnaptysBio Gears Up For Key Trial Readouts In Rheumatoid Arthritis And Lung Cancer

Shares of AnaptysBio Inc. (ANAB) are down over 50% from their 52-week high of $41.31, recorded last August, with the stock now hovering around the $20 level.

from RTT - Top Story https://ift.tt/Xwb10U6
via IFTTT